Dornase Alpha Compared to Hypertonic Saline for Lung Atelectasis in Critically Ill Patients

被引:11
作者
Youness, Houssein A. [1 ]
Mathews, Kathryn [2 ]
Elya, Marwan K. [1 ]
Kinasewitz, Gary T. [1 ]
Keddissi, Jean I. [1 ]
机构
[1] Oklahoma City VA Med Ctr, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Pharm, Oklahoma City, OK USA
关键词
atelectasis; mechanical ventilation; Dornase alpha; hypertonic saline; RECOMBINANT HUMAN DNASE; POSTOPERATIVE PULMONARY COMPLICATIONS; CYSTIC-FIBROSIS; AIRWAY SECRETIONS; CONTROLLED-TRIAL; SPUTUM; YOUNG;
D O I
10.1089/jamp.2011.0954
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Despite the lack of randomized trials, nebulized Dornase alpha and hypertonic saline are used empirically to treat atelectasis in mechanically ventilated patients. Our objective was to determine the clinical and radiological efficacy of these medications as an adjunct to standard therapy in critically ill patients. Methods: Mechanically ventilated patients with new onset (<48 h) lobar or multilobar atelectasis were randomized into three groups: nebulized Dornase alpha, hypertonic (7%) saline or normal saline every 12 h. All patients received standard therapy, including chest percussion therapy, kinetic therapy, and bronchodilators. The primary endpoint was the change in the daily chest X-ray atelectasis score. Results: A total of 33 patients met the inclusion criteria and were randomized equally into the three groups. Patients in the Dornase alpha group showed a reduction of 2.18 +/- 1.33 points in the CXR score from baseline to day 7, whereas patients in the normal saline group had a reduction of 1.00 +/- 31.79 points, and patients in the hypertonic saline group showed a score reduction of 1.09 +/- 1.51 points. Pairwise comparison of the mean change of the CXR score showed no statistical difference between hypertonic saline, normal saline, and dornase alpha. Airway pressures as well as oxygenation, expressed as PaO2/FIO2 and time to extubation also were similar among groups. During the study period the rate of extubation was 54% (6/11), 45% (5/11), and 63% (7/11) in the normal saline, hypertonic saline, and Dornase alpha groups, respectively (p = 0.09). No treatment related complications were observed. Conclusions: There was no significant improvement in the chest X-ray atelectasis score in mechanically ventilated patients with new onset atelectasis who were nebulized with Dornase alpha twice a day. Hypertonic saline was no more effective than normal saline in this population. Larger randomized control trials are needed to confirm our results.
引用
收藏
页码:342 / 348
页数:7
相关论文
共 30 条
  • [1] Predictors of postoperative pulmonary complications following abdominal surgery
    BrooksBrunn, JA
    [J]. CHEST, 1997, 111 (03) : 564 - 571
  • [2] Using Chest Vibration Nursing Intervention to Improve Expectoration of Airway Secretions and Prevent Lung Collapse in Ventilated ICU Patients: A Randomized Controlled Trial
    Chen, Yu-Chih
    Wu, Li-Fen
    Mu, Pei-Fan
    Lin, Li-Hwa
    Chou, Shin-Shang
    Shie, Huei-Guan
    [J]. JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2009, 72 (06) : 316 - 322
  • [3] Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns
    Dilmen, Ugur
    Karagol, Belma Saygili
    Oguz, Serife Suna
    [J]. PEDIATRICS INTERNATIONAL, 2011, 53 (03) : 328 - 331
  • [4] Pulmonary atelectasis - A pathogenic perioperative entity
    Duggan, M
    Kavanagh, BP
    [J]. ANESTHESIOLOGY, 2005, 102 (04) : 838 - 854
  • [5] EJLERTSEN T, 1989, ACTA CHIR SCAND, V155, P93
  • [6] A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis
    Elkins, MR
    Robinson, M
    Rose, BR
    Harbour, C
    Moriarty, CP
    Marks, GB
    Belousova, EG
    Xuan, W
    Bye, PTP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (03) : 229 - 240
  • [7] EFFECT OF AEROSOLIZED RECOMBINANT HUMAN DNASE ON EXACERBATIONS OF RESPIRATORY SYMPTOMS AND ON PULMONARY-FUNCTION IN PATIENTS WITH CYSTIC-FIBROSIS
    FUCHS, HJ
    BOROWITZ, DS
    CHRISTIANSEN, DH
    MORRIS, EM
    NASH, ML
    RAMSEY, BW
    ROSENSTEIN, BJ
    SMITH, AL
    WOHL, ME
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10) : 637 - 642
  • [8] POLY-ELECTROLYTE BEHAVIOR IN MUCUS GLYCOPROTEINS
    HARDING, SE
    CREETH, JM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 746 (1-2) : 114 - 119
  • [9] DNase and atelectasis in non-cystic fibrosis pediatric patients
    Hendriks, T
    de Hoog, M
    Lequin, MH
    Devos, AS
    Merkus, PJFM
    [J]. CRITICAL CARE, 2005, 9 (04): : R351 - R356
  • [10] Dornase alfa for cystic fibrosis
    Jones, Ashley P.
    Wallis, Colin
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (03):